MQT $10.06 -0.0497%
HOME.L $38.05 0%
MESO $3.63 -0.8197%
NRXPW $0.15 -6.25%
SPEQ.L $46.17 0.1464%
DFIB.L $9.17 0%
ASRVP $27.31 0%
SGHT $9.97 -0.1503%
BRNG.L $3 398.50 -1.0338%
TCN.L $4.50 0%
MRIT.L $45.00 -3.2258%
GXC $76.59 -2.458%
KGP.L $63.65 1.0317%
0094.HK $0.07 -5.1948%
CCAC $7.05 0%
0P00017UWR.L $16 864.10 0.2461%
SMCI $133.74 -1.9717%
NDSN $215.42 -0.3792%
AGQ $30.42 -1.6486%
3601.HK $1.33 -0.7463%
ADXN $0.90 1.2261%
FLR $25.83 -2.3809%
NRIX $10.13 -0.4912%
MLONL.PA $2.90 0%
RYAM $4.36 -8.5084%
QFTA-UN $10.19 0%
AAVC.L $47.60 0%
IGOV $39.97 -1.1133%
CRW.L $1 545.00 2.3179%
SANB $10.21 0%
P9D.SI $0.70 0%
0422.HK $0.60 0%
MSAC $10.17 0%
0099.HK $1.72 1.1765%
DOG $33.68 0.5673%
ADV.L $0.18 0%
GTH $0.93 -0.0323%
0876.HK $0.04 -12.766%
CPAQ $10.33 0%
EXAS $78.97 1.1528%
2088.HK $0.07 -10.9589%
1847.HK $0.89 -4.3011%
0286.HK $0.50 -3.8462%
MITT $5.30 -0.1883%
TA $86.01 0%
WSBF $13.13 -1.3524%
AMNB $25.75 -0.9996%
1107.HK $0.11 0%
CHRW $99.21 -0.0906%
MAN.PA $105.00 0%
LQDA.L $5.52 -0.2529%
KACLU $10.29 0%
BNKU.L $25.91 0%
MPC $109.46 -0.5813%
SINO $4.19 0%
DEHP $22.89 -0.919%
TDW $44.42 -0.045%
IPAX $10.42 0%
MTC.L $5.90 -10.6061%
VAC $122.74 -1.3265%
IGN $61.98 0.1022%
0A26.L $12.23 0.5759%
OTMOW $0.02 4.2373%
PZZA $76.32 -1.6686%
PFF $29.68 -0.1299%
INN-PF $17.97 0%
ITUB4.SA $26.79 -1.3623%
MAU.PA $3.39 -0.2939%
USMV.L $271.70 0.1105%
PHTM.L $77.20 0%
MKC-V $89.30 0.904%
1023.HK $0.83 -1.1905%
ECOZ $34.26 0%
ENC.MC $3.45 1.3506%
DVT.PA $168.50 0%
SBS $10.64 8.5204%
ALHUN.PA $12.80 -0.7752%
VEON $18.75 -2.3698%
IES.L $38.50 -7.2289%
MHNC $17.16 0.5822%
0J5I.L $140.96 0.113%
CPAAW $0.16 -4.0842%
TRMT $5.22 0%
MTR.L $9.06 0%
1643.HK $0.48 2.1277%
KEYS $144.68 0.1176%
0HCZ.L $118.33 1.1281%
PRAU.L $25.73 0%
8509.HK $0.32 -3.0769%
1270.HK $1.03 0%
WBS-PG $19.75 -0.0506%
ISWN $19.70 -0.227%
BLU $14.49 -0.0345%
BJ $70.61 -2.0594%
EQPA3.SA $6.47 2.2117%
WGLD $16.10 0%
PCT $7.10 -7.5169%
GRX $10.01 0%
ALBIO.PA $8.53 -0.6985%
HBMD $23.30 0%
Eng
Логотип
Eng
Лого

IceCure Medical Ltd ICCM

$1.26

На 18:04, 12 мая 2023

+356.35%

Потенциал через год

Ключевые показатели

  • Marketcap

    57257367.00000000

  • week52high

    4.73

  • week52low

    0.75

  • Revenue

    3085000

  • P/E TTM

    -3

  • Beta

    1.37981800

  • EPS

    -0.45000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    17 мая 2023 г. в 04:00

Описание компании

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

  • Изображение

    3 Tips for Identifying Penny Stocks With High Potential

    PennyStocks

    21 дек 2022 г. в 06:00

    Use these tips for finding penny stocks to buy in 2022 The post 3 Tips for Identifying Penny Stocks With High Potential appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  • Изображение

    IceCure Medical rockets higher on positive study data showing effectiveness of ProSense kidney tumor treatment

    Proactive Investors

    20 дек 2022 г. в 11:55

    Shares of IceCure Medical Ltd (NASDAQ:ICCM) went on a tear after a study revealed its ProSense treatment was safe and effective in fighting kidney tumors. ProSense is a liquid nitrogen cryoablation solution that is capable of destroying tumors safely without the need for surgery.

  • Изображение

    1,000% Move in a Day: Medical Stock Soars on Positive Data

    Zacks Investment Research

    19 дек 2022 г. в 20:18

    IceCure Medical, a little-known medical device company surged in after-hours trading Monday. IceCure's Prosense technology proved to be a safe and effective treatment for cancerous kidney tumors.

  • Изображение

    IceCure Medical Ltd (ICCM) Q3 2022 Earnings Call Transcript

    Seeking Alpha

    05 дек 2022 г. в 10:20

    IceCure Medical Ltd (NASDAQ:ICCM ) Q3 2022 Results Conference Call December 2, 2022 8:00 AM ET Company Participants Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Officer Hania Bednarski - Oncoplastic Breast Surgeon and Cryoablation Specialist Conference Call Participants Ben Haynor - Alliance Global Partners Anthony Vendetti - Maxim Group Kemp Dolliver - Brookline Capital Markets Operator Welcome to IceCure's Conference Call on the Financial Results for the Nine Months Ended September 30, 2022, and update on recent operational highlights. Management will provide an overview of IceCure's financial results as well as clinical, commercial and operational highlights.

  • Изображение

    TIME CHANGE: IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

    PRNewsWire

    29 ноя 2022 г. в 08:00

    CAESAREA, Israel , Nov. 29, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it will report its business and financial results as of and for the nine months ended September 30, 2022 on Monday, December 5, 2022 with a press release issued at 7:00 a.m.